164 related articles for article (PubMed ID: 24900656)
1. Discovery of novel N-substituted oxindoles as selective m1 and m4 muscarinic acetylcholine receptors partial agonists.
Sumiyoshi T; Enomoto T; Takai K; Takahashi Y; Konishi Y; Uruno Y; Tojo K; Suwa A; Matsuda H; Nakako T; Sakai M; Kitamura A; Uematsu Y; Kiyoshi A
ACS Med Chem Lett; 2013 Feb; 4(2):244-8. PubMed ID: 24900656
[TBL] [Abstract][Full Text] [Related]
2. Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M(1) and M(4) muscarinic acetylcholine receptors agonists.
Uruno Y; Konishi Y; Suwa A; Takai K; Tojo K; Nakako T; Sakai M; Enomoto T; Matsuda H; Kitamura A; Sumiyoshi T
Bioorg Med Chem Lett; 2015 Nov; 25(22):5357-61. PubMed ID: 26428869
[TBL] [Abstract][Full Text] [Related]
3. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
Lazareno S; Dolezal V; Popham A; Birdsall NJ
Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
[TBL] [Abstract][Full Text] [Related]
5. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
[TBL] [Abstract][Full Text] [Related]
6. Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.
Felder CC; Goldsmith PJ; Jackson K; Sanger HE; Evans DA; Mogg AJ; Broad LM
Neuropharmacology; 2018 Jul; 136(Pt C):449-458. PubMed ID: 29374561
[TBL] [Abstract][Full Text] [Related]
7. Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M(1) and M(4) muscarinic acetylcholine receptors agonists.
Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
Bioorg Med Chem Lett; 2013 Aug; 23(16):4644-7. PubMed ID: 23816371
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Development of Muscarinic Acetylcholine M
Takai K; Enomoto T
Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
[TBL] [Abstract][Full Text] [Related]
9. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
10. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
[TBL] [Abstract][Full Text] [Related]
11. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
Suwa A; Konishi Y; Uruno Y; Takai K; Nakako T; Sakai M; Enomoto T; Ochi Y; Matsuda H; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jul; 24(13):2909-12. PubMed ID: 24852118
[TBL] [Abstract][Full Text] [Related]
13. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
14. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
Akam EC; Challiss RA; Nahorski SR
Br J Pharmacol; 2001 Feb; 132(4):950-8. PubMed ID: 11181437
[TBL] [Abstract][Full Text] [Related]
15. Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline.
Thorn CA; Moon J; Bourbonais CA; Harms J; Edgerton JR; Stark E; Steyn SJ; Butter CR; Lazzaro JT; O'Connor RE; Popiolek M
ACS Chem Neurosci; 2019 Mar; 10(3):1753-1764. PubMed ID: 30480428
[TBL] [Abstract][Full Text] [Related]
16. Positive allosteric modulation of M
Yohn SE; Conn PJ
Neuropharmacology; 2018 Jul; 136(Pt C):438-448. PubMed ID: 28893562
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
Eglen RM
Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
[TBL] [Abstract][Full Text] [Related]
18. Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes.
Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Kuonen D; Lazareno S; Popham A; Sugimoto M
Life Sci; 1997; 60(13-14):1047-52. PubMed ID: 9121346
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptor subtypes are differentially distributed in the rat cochlea.
Khan KM; Drescher MJ; Hatfield JS; Khan AM; Drescher DG
Neuroscience; 2002; 111(2):291-302. PubMed ID: 11983315
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]